Day three of the Future of Bio/Pharmaceutical Analysis Virtual Summit 2026 will spotlight innovations in pharmaceutical manufacturing, emphasizing the role of digital technologies and AI in transforming the industry.
Scheduled for June 25, 2026, this segment of the summit will convene experts from academia, industry, and technology to tackle the challenges of translating innovative manufacturing techniques into actionable strategies. The day features three sessions, each addressing different aspects of this transformation.
The first panel will provide an overview of digital transformation in pharma manufacturing, discussing the integration of technologies like digital twins and the Internet of Things. Industry experts will assess where these technologies are effective and highlight the uneven pace of adoption across the sector.
The second session will focus specifically on artificial intelligence, exploring its practical applications in the manufacturing value chain, including process optimization and quality assurance. Panelists will share insights on designing and implementing AI solutions that go beyond pilot projects to create sustainable operations.
Finally, a session led by Professor Clifford V. Rossi will address the financial aspects of adopting continuous manufacturing. By applying financial modeling techniques, he aims to help attendees construct a compelling business case for continuous manufacturing that resonates with CFOs and decision-makers. Collectively, these discussions will underscore that successful transformation in pharmaceutical manufacturing hinges not only on technological advancements but also on effective financial communication and strategy.